| Title : [A transdermal patch of rivastigmine (Exelon)] - Salmon_2008_Rev.Med.Liege_63_570 |
| Author(s) : Salmon E |
| Ref : Rev Med Liege , 63 :570 , 2008 |
|
Abstract :
Inhibitors of acetylcholinesterase provide a modest symptomatic benefit for a majority of patients with Alzheimer's disease. Cholinergic "secondary" effects are variable, but sometimes quite invalidating. Nausea and vomiting appear to be linked to peak plasma concentration of the drug. A transdermal patch of rivastigmine is available that allows to obtain a lower peak of concentration, less gastro-intestinal side effects, and an efficacy similar to the oral capsules of rivastigmine. |
| PubMedSearch : Salmon_2008_Rev.Med.Liege_63_570 |
| PubMedID: 19051514 |
Salmon E (2008)
[A transdermal patch of rivastigmine (Exelon)]
Rev Med Liege
63 :570
Salmon E (2008)
Rev Med Liege
63 :570